Wells Fargo Remains a Buy on Omega Healthcare (OHI)

Wells Fargo analyst John Kilichowski maintained a Buy rating on Omega Healthcare today and set a price target of $48.00.

TipRanks Black Friday Sale

• Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
• Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off

According to TipRanks, Kilichowski is a 2-star analyst with an average return of 2.0% and a 41.82% success rate. Kilichowski covers the Real Estate sector, focusing on stocks such as Welltower, EPR Properties, and Four Corners Property.

In addition to Wells Fargo, Omega Healthcare also received a Buy from UBS’s Michael Goldsmith in a report issued on November 18. However, on November 17, Bank of America Securities maintained a Hold rating on Omega Healthcare (NYSE: OHI).

Based on Omega Healthcare’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $311.59 million and a net profit of $179.72 million. In comparison, last year the company earned a revenue of $276.03 million and had a net profit of $111.76 million

Based on the recent corporate insider activity of 17 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of OHI in relation to earlier this year. Earlier this month, Vikas Gupta, the CIO of OHI bought 11,500.00 shares for a total of $494,040.00.